patients with cirrhosis are at greatest risk for development of hepatocellular carcinoma hcc and should undergo semiannual surveillance using ultrasound with or without alpha fetoproteinpatients with positive surveillance testing should undergo contrastenhanced mri or 4phase ct for diagnostic evaluationthere are therapeutic options for most patients with any tumor stage however treatment decisions must be individualized after accounting for degree of liver dysfunction and patient performance statusa multidisciplinary approach to care is recommended for optimal communication and treatment deliverythe aim of this review is to provide an uptodate summary of the diagnosis and management of hcccopyright  2014 elsevier inc all rights reserved